Roboat Secures €550K to Advance Autonomous Waterway Transport

Roboat, a pioneering startup from Amsterdam spun out from MIT and the Amsterdam Institute for Advanced Metropolitan Solutions (AMS), has secured €550,000 in funding from prominent Dutch VC firms LUMO Labs and SHIFT Invest. This investment aims to propel Roboat’s mission of automating urban waterway transport, fostering safer, more efficient, and sustainable logistics solutions. Founded…

Read More

Truvian Health Secures $74M to Democratize Access to Blood Testing Anywhere

Truvian Health, a pioneering force in healthcare innovation, has announced a significant milestone with the successful closure of a $74 million funding round aimed at revolutionizing the accessibility of blood testing. This funding, led by Wittington Ventures and Great Point Ventures, marks a pivotal moment for Truvian as it prepares to advance its groundbreaking blood…

Read More

Courier Health Secures $16.5 Million Investment to Revolutionize Patient Engagement in Life Sciences

Courier Health, a trailblazing technology firm dedicated to enhancing patient support within the life sciences sector, has announced a significant milestone with the closure of a $16.5 million Series A funding round. Led by Norwest Venture Partners and supported by existing investor Work-Bench, this financing underscores a pivotal moment for the company as it continues…

Read More
Roee Barak, Founder and CEO of Upword

Revolutionizing Research: Upword Launches AI-Powered Tool and Secures $3 Million in Funding

Upword, a pioneering force in knowledge management solutions, has unveiled its cutting-edge AI-powered research companion tool, marking a pivotal moment in the evolution of scholarly pursuits. Alongside this milestone, the company has successfully concluded a $3 million pre-seed funding round, underscoring confidence from investors including Telefonica (Wayra X), Go Ahead Ventures, and Goodwater Capital. Upword’s…

Read More

NeOnc Technologies Secures $18.5 Million to Propel Breakthrough Brain Cancer Therapies Through Phase II Trials

NeOnc Technologies Holdings, Inc., a forefront player in clinical-stage biotechnology, has successfully concluded an $18.5 million financing round aimed at advancing its innovative approach to treating brain cancer. This funding milestone includes new equity investment and debt conversions, reflecting a substantial increase in NeOnc’s valuation and reinforcing its commitment to pioneering neurological therapeutics. The financing…

Read More

Mantle Secures $20 Million in Series C Funding to Propel Innovation in Metal 3D Printing Technology

Mantle, a pioneer in precision metal 3D printing for tooling applications, has achieved a significant milestone with the successful closure of a $20 million Series C funding round. This latest investment, led by Schooner Capital and supported by existing investors including Fine Structure Ventures and Foundation Capital, brings Mantle’s total funding to over $61.5 million….

Read More

SURGAR Secures €11M to Revolutionize Augmented Reality in Surgery

In a significant advancement for surgical technology, SURGAR, a French startup specializing in augmented reality (AR) solutions for minimally invasive surgery, has successfully closed an €11 million funding round. This investment marks a pivotal moment for the company as it seeks to transform the landscape of surgical procedures through innovative technology. SURGAR’s cutting-edge AR software…

Read More
Sirona Technologies Team

Sirona Technologies Secures €6M to Advance Direct Air Capture Technology

In a significant stride towards combating climate change, Sirona Technologies has successfully raised €6 million in a Seed round to propel its innovative Direct Air Capture (DAC) technology. This funding, co-led by LocalGlobe and XAnge, underscores growing investor confidence in Sirona’s mission to revolutionize carbon removal from the atmosphere. Founded in 2023 and headquartered in…

Read More

RareCyte Secures $20M to Expand Orion™ Spatial Biology Platform and Precision Biology Services

RareCyte, Inc., a pioneering Life Sciences company renowned for its Precision Biology platforms, has announced the successful completion of a $20 million financing round aimed at bolstering its Orion™ Spatial Biology platform. This funding, sourced from a blend of new and existing investors, including Forest Road, Arboretum Ventures, and F-Prime Capital, underscores RareCyte’s commitment to…

Read More